1-7 of 7
Authors: Kaytora Long-James
Journal Article
EXTH-58. BLOCKING IMMUNE CHECKPOINT— LAIR1: DISRUPTING THE LAIR1—FXIII-A—COLLAGEN IMMUNOSUPPRESSIVE CIRCUIT FOR ENHANCED ANTITUMOR THERAPEUTICS
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii250, https://doi.org/10.1093/neuonc/noae165.0989
Published: 11 November 2024
Journal Article
EXTH-09. GENE MODIFICATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS FOR IMPROVEMENT OF IMMUNOTHERAPIES FOR MALIGNANT GLIOMAS
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii238, https://doi.org/10.1093/neuonc/noae165.0940
Published: 11 November 2024
Journal Article
EXTH-22. AN IND-ENABLED STUDY USING A NOVEL CHECKPOINT BLOCKADE OF LAIR1 FOR GLIOBLASTOMA THERAPY
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v228, https://doi.org/10.1093/neuonc/noad179.0875
Published: 10 November 2023
Journal Article
EXTH-11. ADOPTIVE CELLULAR THERAPY OVERCOMES GLIOMA IMMUNE ESCAPE BY DISRUPTING MDSC PROLIFERATION AND RECRUITMENT
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v226, https://doi.org/10.1093/neuonc/noad179.0865
Published: 10 November 2023
Journal Article
IMMU-36. PD-1KO HEMATOPOIETIC STEM CELLS RAPIDLY DIFFERENTIATE INTO GLIOMA-INFILTRATING EFFECTOR T-CELLS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v150, https://doi.org/10.1093/neuonc/noad179.0568
Published: 10 November 2023
Journal Article
TMIC-55. IMMUNE DIGITAL-SPATIAL PROFILING AND CHARACTERIZATION OF GLIOMA MICROENVIRONMENT AFTER ADOPTIVE CELLULAR THERAPY
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii283, https://doi.org/10.1093/neuonc/noac209.1099
Published: 14 November 2022
Journal Article
IMMU-42. ADOPTIVE HEMATOPOIETIC STEM CELL AND APD1 THERAPY CONVERGE IN THE THYMUS TO PROMOTE ANTI-GLIOBLASTOMA IMMUNITY
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii140, https://doi.org/10.1093/neuonc/noac209.539
Published: 14 November 2022
